United States: FDA Issues Long-Awaited Action Plan For Artificial Intelligence/Machine Learning-Based Software As A Medical Device - Duane Morris LLP
On January 12, 2021, the FDA issued its long-awaited action plan concerning the regulation of artificial intelligence (AI) and machine learning (ML)-based Software As a Medical Device (SaMD).
Full Article